NASDAQ: HQYHealthequity Inc Stock
$92.28+0.74 (+0.81%)
Updated Sep 17, 2025
HQY Price
$92.28
Fair Value Price
$143.57
Market Cap
$7.95B
52 Week Low
$74.07
52 Week High
$116.65
P/E
54.93x
P/B
3.7x
P/S
6.62x
PEG
1.58x
Dividend Yield
N/A
Revenue
$1.27B
Earnings
$145.84M
Gross Margin
66.4%
Operating Margin
19.58%
Profit Margin
11.5%
Debt to Equity
0.59
Operating Cash Flow
$367M
Beta
0.72
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HQY Overview
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HQY's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
HQY
Ranked#10 of 43
Ranked#10 of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $20.83 | A | |
| $17.47 | A | |
| $17.78 | B |
Be the first to know about important HQY news, forecast changes, insider trades & much more!
HQY News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HQY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HQY ($92.28) is undervalued by 35.73% relative to our estimate of its Fair Value price of $143.57 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HQY ($92.28) is significantly undervalued by 35.73% relative to our estimate of its Fair Value price of $143.57 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HQY ($92.28) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HQY due diligence checks available for Premium users.
Valuation
HQY fair value
Fair Value of HQY stock based on Discounted Cash Flow (DCF)
Price
$92.28
Fair Value
$143.57
Undervalued by
35.73%
HQY ($92.28) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HQY ($92.28) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HQY ($92.28) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
HQY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
54.93x
Industry
85.39x
Market
37.36x
HQY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HQY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
HQY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.7x
Industry
4.12x
HQY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HQY price to earnings growth (PEG)
For valuing profitable companies with growth potential
HQY is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
HQY's financial health
Profit margin
Revenue
$325.8M
Net Income
$59.9M
Profit Margin
18.4%
HQY's Earnings (EBIT) of $248.41M... subscribe to Premium to read more.
Interest Coverage Financials
HQY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.4B
Liabilities
$1.3B
Debt to equity
0.59
HQY's short-term assets ($492.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HQY's long-term liabilities ($1.15B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HQY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HQY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$135.9M
Investing
-$11.2M
Financing
-$108.1M
HQY's operating cash flow ($366.90M)... subscribe to Premium to read more.
Debt Coverage Financials
HQY vs Health Information Service Stocks
Healthequity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.